Generics (and big savings) coming for Plavix, Singulair and Cymbalta
News | 12 June 2012
Excellus Blue Cross Blue Shield says generics are coming for Plavix, Singulair and Cymbalta. If you take either of these drugs, we want to hear from you.
Click on the link to read the full article at News 10NBC
(This link will open in a new window)
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
